Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | PPARG | P37231 | 7/20 | 0.52 |
| ▸ | PPARD | Q03181 | 7/20 | 0.52 |
| ▸ | PPARA | Q07869 | 7/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TLR2 | O60603 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL11836943 | 1.00 | CES2 (0.59) | CES2MEN1KMT2ATHRBHTT | |
| Propionic Acid SCHEMBL3921327 | 1.00 | CES2 (0.59) | CES2MEN1KMT2ATHRBHTT | |
| Propionic Acid SCHEMBL27871359 | 0.98 | CES2 (0.57) | CES2MEN1KMT2ATHRBHTT | |
| Propionic Acid SCHEMBL11694208 | 0.98 | MEN1 (0.61) | CES2MEN1KMT2ATHRBHTT | |
| Propionic Acid SCHEMBL11837630 | 0.98 | CES2 (0.56) | CES2MEN1KMT2ATHRBHTT | |
| Propionic Acid SCHEMBL2254834 | 0.91 | MEN1 (0.59) | CES2MEN1KMT2ATHRBHTT | |
| Bicarbonate SCHEMBL27976205 | 0.90 | CES2 (0.64) | CES2MEN1KMT2ATHRBHTT | |
| Bicarbonate SCHEMBL15512279 | 0.90 | CES2 (0.64) | CES2MEN1KMT2ATHRBHTT | |
| Propionic Acid SCHEMBL11837655 | 0.90 | TSHR (0.56) | CES2MEN1KMT2ATHRBHTT | |
| Bicarbonate SCHEMBL8198778 | 0.90 | CES2 (0.64) | CES2MEN1KMT2ATHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1608 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225987-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2023-07-20 | — | — | US | claimed |
| CN-116139029-A | Water-in-oil type cool itching-relieving ointment and preparation method thereof | 广州翀潇生物科技有限公司 | 2023-05-23 | — | — | CN | claimed |
| EP-4171529-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2023-05-03 | — | — | EP | claimed |
| WO-2021262917-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2021-12-30 | — | — | WO | claimed |
| EP-3820448-A2 | TOPICAL DETOMIDINE FORMULATIONS | Clexio Biosciences Ltd. (IL) | 2021-05-19 | — | — | EP | claimed |
| US-20210137830-A1 | TOPICAL DETOMIDINE FORMULATIONS | CLEXIO BIOSCIENCES LTD. (IL) | 2021-05-13 | — | — | US | claimed |
| EP-3496703-B1 | MOXIDECTIN TOPICAL LIQUID FORMULATIONS | NORBROOK LAB LTD (GB) | 2021-05-12 | — | — | EP | claimed |
| US-10675240-B2 | Transdermal cannabinoid formulations | MM TECHNOLOGY HOLDINGS, LLC (US) | 2020-06-09 | — | — | US | claimed |
| WO-2020067968-A1 | NEW COMPOSITIONS COMPRISING CATECHIN POLYPHENOLS | FARMETT LÄKEMEDEL AB (SE) | 2020-04-02 | — | — | WO | claimed |
| WO-2020012415-A2 | TOPICAL DETOMIDINE FORMULATIONS | CLEXIO BIOSCIENCES LTD. (IL) | 2020-01-16 | — | — | WO | claimed |
| US-6087393-A | PREVENTING FROM OXIDATION BY DISPERSING 1-ASCORBIC ACID IN A MIXED GLYCOL CARRIER INCLUDING PROPYLENE GLYCOL, BUTYLENE GLYCOL, AND A STABILIZER | IGEN, INC. (US) | 2000-07-11 | — | — | US | claimed |
| EP-0778765-A4 | COSMETIC MAKE-UP COMPOSITIONS | PROCTER & GAMBLE (US) | 2000-04-19 | — | — | EP | claimed |
| US-6013269-A | OIL-IN-WATER EMULSION COMPRISING VOLATILE SILICONE OIL AND/OR VOLATILE HYDROCARBON OIL, NON-VOLATILE OIL, PIGMENT AND ORGANIC AMPHIPHILIC MATERIAL CAPABLE OF FORMING SMECTIC LYOTROPIC LIQUID CRYSTALS IN PRODUCT OR ON THE SKIN | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-11 | — | — | US | claimed |
| EP-0778765-A1 | COSMETIC MAKE-UP COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-18 | — | — | EP | claimed |
| EP-0432494-B1 | Pour-on formulations effective for the control of internal and external parasites of homothermic animals | AMERICAN CYANAMID CO (US) | 1997-02-05 | — | — | EP | claimed |
| WO-1996011665-A1 | COSMETIC MAKE-UP COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-04-25 | — | — | WO | claimed |
| EP-0432494-A2 | Pour-on formulations effective for the control of internal and external parasites of homothermic animals | AMERICAN CYANAMID COMPANY (US) | 1991-06-19 | — | — | EP | claimed |
| US-4889845-A | POLYDIMETHYLSILOXANE MIXTURE; STORAGE STABILITY; E-TYPE PROSTAGLANDINS | AMERICAN CYANAMID COMPANY (US) | 1989-12-26 | — | — | US | claimed |
| EP-0249193-A2 | Vehicle for topical application of pharmaceuticals | AMERICAN CYANAMID COMPANY (US) | 1987-12-16 | — | — | EP | claimed |
| EP-0249194-A2 | Topical prostaglandin formulations | AMERICAN CYANAMID COMPANY (US) | 1987-12-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10675240-B2 | Transdermal cannabinoid formulations | TNNC1, CNR2, TNNT2 | CES2 794/4885MEN1 2000/4885KMT2A 2998/4885 |
| US-20230225987-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | TSLP, SQLE, DHCR7 | CES2 3197/4885MEN1 4400/4885KMT2A 4209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.